These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. Four keys to 100 per cent success in tetanus prophylaxis. Furste W. Am J Surg; 1974 Nov; 128(5):616-23. PubMed ID: 4613194 [No Abstract] [Full Text] [Related]
8. When to try antineoplastic agents in psoriasis. McDonald CJ. Med Times; 1977 Aug; 105(8):68-80. PubMed ID: 577996 [No Abstract] [Full Text] [Related]
9. [Apropos of a case of tetanus localized in the limbs]. Aubry P, Colle M, Giraud J, Massacrier A, Thomas J. Bull Soc Pathol Exot Filiales; 1974 Aug; 67(3):267-70. PubMed ID: 4480455 [No Abstract] [Full Text] [Related]
10. Treatment of psoriatic arthritis with azaribine. Levine S, Paulus HE. Arthritis Rheum; 1976 Aug; 19(1):21-8. PubMed ID: 766762 [Abstract] [Full Text] [Related]
11. [Preventive tetanus immunization and avoidance of side effects of booster immunization]. Schröder JP, Kuhlmann WD. Dtsch Med Wochenschr; 1992 Dec 11; 117(50):1903-6. PubMed ID: 1459020 [Abstract] [Full Text] [Related]
12. Changes in serum and urine amino acids in patients with progressive systemic sclerosis treated with 6-azauridine triacetate. Slavik M, Lovenberg W, Keiser HR. Biochem Pharmacol; 1973 Jun 01; 22(11):1295-300. PubMed ID: 4727783 [No Abstract] [Full Text] [Related]
13. New indications for 6-azauridine treatment in man. A review. Elis J, Rasková H. Eur J Clin Pharmacol; 1972 Mar 01; 4(2):77-81. PubMed ID: 4570456 [No Abstract] [Full Text] [Related]
14. Azaribine therapy for psoriasis. Evaluation of potential effects on the liver and other organ systems. Keefer RA, Roenigk HH, Hawk WA. Arch Dermatol; 1975 Jul 01; 111(7):853-6. PubMed ID: 1173747 [Abstract] [Full Text] [Related]
16. [Effect of different RNA preparations on primary immune response to immunization with tetanus antitoxin]. Kulakova GS, Cherniavs'kii VI, Lisenko AI, Mikulins'kii IuI. Mikrobiol Zh; 1975 Jul 01; 37(1):103-5. PubMed ID: 1214622 [No Abstract] [Full Text] [Related]
17. [Immunogenicity of tetanus toxoid used in conjunction with high doses of tetanus antitoxin]. Galazka A, Januszkiewicz J, Sporzyńska Z, Adamczyk J. Przegl Epidemiol; 1974 Jul 01; 28(3):345-53. PubMed ID: 4409780 [No Abstract] [Full Text] [Related]